LifePoint Health (NASDAQ:LPNT) issued an update on its FY18 earnings guidance on Friday morning. The company provided EPS guidance of $4.00-4.53 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.09. The company issued revenue guidance of $6.35-6.43 billion, compared to the consensus revenue estimate of $6.49 billion.
Shares of LifePoint Health (NASDAQ:LPNT) opened at $42.75 on Friday. LifePoint Health has a 12-month low of $41.45 and a 12-month high of $67.95. The company has a debt-to-equity ratio of 1.24, a quick ratio of 1.65 and a current ratio of 1.85. The firm has a market cap of $1,958.96, a price-to-earnings ratio of 10.11, a PEG ratio of 1.14 and a beta of 0.52.
LifePoint Health (NASDAQ:LPNT) last posted its quarterly earnings data on Friday, February 23rd. The company reported $0.77 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.83 by ($0.06). LifePoint Health had a return on equity of 7.01% and a net margin of 2.45%. The firm had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.58 billion. During the same quarter last year, the company earned $1.07 earnings per share. The company’s quarterly revenue was down 7.2% compared to the same quarter last year. research analysts anticipate that LifePoint Health will post 3.64 EPS for the current year.
LifePoint Health announced that its board has authorized a stock buyback program on Friday, October 27th that permits the company to buyback $200.00 million in shares. This buyback authorization permits the company to repurchase shares of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s leadership believes its stock is undervalued.
LPNT has been the subject of a number of research reports. Mizuho set a $50.00 price target on shares of LifePoint Health and gave the stock a hold rating in a report on Friday, October 27th. KeyCorp restated a hold rating on shares of LifePoint Health in a report on Sunday, October 29th. Robert W. Baird set a $55.00 price target on shares of LifePoint Health and gave the stock a buy rating in a report on Monday, October 30th. Raymond James Financial restated a market perform rating on shares of LifePoint Health in a report on Monday, October 30th. Finally, Royal Bank of Canada reduced their price target on shares of LifePoint Health to $65.00 and set an outperform rating for the company in a report on Monday, October 30th. One analyst has rated the stock with a sell rating, fifteen have issued a hold rating and five have issued a buy rating to the stock. The company presently has a consensus rating of Hold and an average target price of $58.13.
In other news, Director Marguerite Kondracke sold 3,907 shares of LifePoint Health stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $44.73, for a total transaction of $174,760.11. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider David M. Dill sold 45,000 shares of LifePoint Health stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $48.52, for a total transaction of $2,183,400.00. Following the transaction, the insider now owns 252,673 shares of the company’s stock, valued at $12,259,693.96. The disclosure for this sale can be found here. 8.76% of the stock is owned by company insiders.
ILLEGAL ACTIVITY WARNING: “LifePoint Health (LPNT) Issues FY18 Earnings Guidance” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another website, it was illegally copied and republished in violation of US & international copyright & trademark law. The legal version of this news story can be read at https://www.dispatchtribunal.com/2018/02/24/lifepoint-health-lpnt-issues-fy18-earnings-guidance.html.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.